Nitric oxide-cyclic GMP system potentiates glucose-induced rise in cytosolic Ca2+ concentration in rat pancreatic β-cells

This publication has 23 references indexed in Scilit:

• Role of nitric oxide in obesity-induced beta cell disease.
  Journal of Clinical Investigation, 1997
• Hydroxylamine, a nitric oxide donor, inhibits insulin release and activates K+ATP channels
  European Journal of Pharmacology, 1996
• Influence of nitric oxide synthase inhibition, nitric oxide and hydroperoxide on insulin release induced by various secretagogues
  British Journal of Pharmacology, 1995
• The effect of nitric oxide donors on insulin secretion, cyclic GMP and cyclic AMP in rat islets of Langerhans and the insulin-secreting cell lines HIT-T15 and RINm5F
  Molecular and Cellular Endocrinology, 1994
• Insulin Secretion from Pancreatic B Cells Caused by L-Arginine-Derived Nitrogen Oxides
  Science, 1992
• Single pancreatic β-cells from normal rats exhibit an initial decrease and subsequent increase in cytosolic free Ca2+ in response to glucose
  Cell Calcium, 1992
• Inhibition of insulin secretion by interleukin‐1β and tumour necrosis factor‐α via an L‐arginine‐dependent nitric oxide generating mechanism
  FEBS Letters, 1990
• Atrial natriuretic factor has a weak insulinotropic action in the isolated perfused rat pancreas
  Zeitschrift für Die Gesamte Experimentelle Medizin, 1990
• Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein.
  Circulation Research, 1989
• Atrial natriuretic peptide (ANP) acts via specific binding sites on cGMP system of rat pancreatic islets without affecting insulin release
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1989